Drug Name:
AFSTYLA Rx

Generic Name and Formulations:
Antihemophilic Factor (recombinant) single chain 250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU; per vial; lyophilized pwd for IV infusion after reconstitution; preservative-free.
Company:
CSL Behring, LLC
Therapeutic Use:
Indications for AFSTYLA:
In patients with Hemophilia A: to treat and control bleeding episodes, for perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.
Limitations Of use:
Not for treating von Willebrand disease.
Adults and Children:
Dosage Required (IU) = Body Weight (kg) × Desired % Factor VIII Increase × 0.5. Individualize. Max infusion rate: 10mL/min. Bleeding: Minor: obtain 20–40% FVIII increase; may repeat every 12–24hrs until resolved; Moderate: obtain 30–60% FVIII increase; may repeat every 12–24hrs until resolved; Major: obtain 60–100% FVIII increase; may repeat every 8–24hrs until resolved. Perioperative: Minor: obtain 30–60% FVIII increase; may repeat every 24hrs for ≥1 day until healed; Major: obtain 80–100% FVIII increase; may repeat every 8–24hrs until adequately healed, then continue for ≥7 days to maintain Factor VIII activity of 30–60%. Routine prophylaxis: ≥12yrs: 20–50 IU/kg 2–3 times weekly; <12yrs: 30–50 IU/kg 2–3 times weekly (more frequent or higher doses may be required).
Contraindications:
Hamster protein sensitivity.
Warnings/Precautions:
Confirm Factor VIII deficiency prior to treatment. Monitor for development of Factor VIII inhibitors. Discontinue if hypersensitivity reactions occur; consider premedication with antihistamines if previous history of hypersensitivity. Pregnancy. Nursing mothers.
Pharmacological Class:
Clotting factor.
Adverse Reactions:
Dizziness, hypersensitivity, paresthesia, rash, erythema, pruritus, pyrexia, inj site pain, chills, feeling hot.
Generic Availability:
NO
How Supplied:
Kit—1 (vial w. diluent + supplies)
Clinical Pain Advisor Articles
- MRS May Accurately Identify Painful Disks in Chronic Low Back Pain
- Examining the Relationships Among Opioid Use, Overdose, and Suicide
- Multispecies Probiotics May Be Effective in Chronic, Episodic Migraine
- Generalized Mechanical Hyperalgesia in Chronic Migraine, Temporomandibular Disorder
- Migraine Symptoms Can Improve Despite Unchanged Pain Avoidance, Endurance
- MRS May Accurately Identify Painful Disks in Chronic Low Back Pain
- Does Opioid Tapering in Chronic Pain Result in Controlled Pain at Taper Completion?
- Spinal Cord Stimulation Shows Long-Term Effectiveness for Refractory Neuropathic Pain
- Color Doppler Ultrasound for the Diagnosis of Sacroiliitis in Inflammatory Back Pain
- An Evidence-Based Road Map to Navigating the Opioid Epidemic
- Headache Frequency, Medication Overuse, and Depression Linked to Migraine
- Giving the Choice of Medical Support During Painful Procedures to Children With Cancer
- Mechanisms of Posttraumatic Headache
- Parents Conflicted About Opioid Use in Children
- Generalized Mechanical Hyperalgesia in Chronic Migraine, Temporomandibular Disorder